Announcing RadOncSmartLearn 2.0,
Free AI-powered platform for mock oral exams
Socratic tutor sessions backed by the latest guidelines.
Complete Speech System, case exhibits, structured follow-up, and mastery tracking and more...
Please welcome David Randall and Shlok Mohanty to the Kaiser Rad/Onc family as our class of 2031. Congratulations and we can't wait for you to be on campus! #match2026#kaiser@KPSCAL@aboutKP
Cognitive cost or disease control in the management of brain metastases from small cell Lung cancer?-an ongoing debate: 🧠cost vs 🎯?
@ovidiohernando@rafagar_cia
@MercedesLópez
@raquel_ciervide
https://t.co/1HggXer9Ji
RT with 5 × 5 Gy for Personalized Treatment of Malignant Epidural Compression: Long-Term Results of the PRE-MODE Trial
Congrats and thanks to Prof Rades for counting on me☺️
https://t.co/Vvso4tv7Dz
In honor of Liver Cancer Awareness Month, we’re featuring @melinda_bachini — Chief Patient Officer and cholangiocarcinoma survivor — from the Cholangiocarcinoma Foundation (@curecc)! Hear her inspiring story and discover all that CCF offers patients and families 💚
What is the role of pre-op RT in esophagus/GEJ cancer post ESOPEC & now MATTERHORN?
I think we all agree pre-op RT not needed for all, but here is my take on 5 settings should still consider.
Key is patient selection, weighing risks of local vs. distant recurrence.
@OncoAlert
Need a refresher on management of WHO grade 4 #glioma?? 🧠🧠🧠
Check out PGY-3 @cyphotons ARRO case here: https://t.co/fLPWPbCaRT
And the 2025 PRO guidelines here: https://t.co/MfaLIWAm6F
@ARRO_org@ASTRO_org@KPSCALnews
Radiation Forgiveness
& Re-irradiation
& Monkeys 🙈🙊🙉
============
I derived a simple equation to use "in clinico"
TL;DR:
To calculate spinal cord re-RT forgiveness,
Understanding the intricate interactions between tumors and the immune system is crucial for developing safe and effective treatments.
Read about this research in an update from the Binkley Lab in our department:
https://t.co/2LZzhCbjOe
🔥 Hot off the press: Ralph Weichselbaum, MD, and his team published a new study in @Nature demonstrating that high-dose radiation to primary tumors can unexpectedly promote tumor growth at metastatic sites.
@rweichselbaum@AndrasPiffko@UChicagoRadonc
https://t.co/yQLKw3gTor
@joshuapalmermd@TrudyWuMD@AtTheBeam Agreed, but possibly more than that. In 2019, while the match rate was far lower than before, the # of applicants to RO was still close to the # of spots available. I assume most soaped candidates at that time still had heavy RO interest. Certainly dropped the years after.
We thought it important to share some unsolicited thoughts on advice re: personal statements that has been passed down through generations of trainees. Congrats to @mattfarrellmd for once again, sharing his literary talent with us all!
For select breast cancer patients with complete response to neoadjuvant systemic therapy, radiotherapy alone without breast surgery may be feasible, as no tumor recurrences were observed at 5-year follow-up. https://t.co/CTooKo9AYB @HenryKuerer HelenMJohnsonMD @SFShaitelmanMD